Clinical Trial Update: Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing dexamethasone to burr hole craniostomy for symptomatic chronic subdural hematoma was terminated with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Virginia | Conditions: Chronic Subdural Hematoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-12-11